President Biden plans to expand vaccination access in places such as doctor’s offices and work settings after failing to reach his July 4 vaccination goal. The administration is also hoping to boost vaccination among adolescents before school starts in the fall. (CNBC Weekly)
Eli Lilly and Boehringer Ingelheim released new data on its drug Jardiance showing it passed the primary endpoint in a trial with heart failure patients. The results come on the heels of Novartis’ heart failure drug Entresto receiving a Food and Drug Administration approval this year. (Endpoints News)
Juul is battling to keep its vape products on the U.S. market with an application to the FDA, despite a myriad of lawsuits and a drop in sales. The FDA will decide on September 9 whether Juul’s products have a public health benefit. (The New York Times)
Biden’s proposed Advanced Research Projects Agency (ARPA) is garnering skepticism as experts worry whether it would create more bureaucracy at the National Institutes of Health. Other administration officials argue the agency could avoid duplication and sculpt its own identity within the NIH. (POLITICO)
Hospitals often charge cash payers and uninsured patients higher prices than others, according to a new study examining hospital rates. Hospital prices have become newly public after a federal rule requiring the cost of services to be transparent took effect this January. (The Wall Street Journal)
